Cytokine, a subdivision of Creative Proteomics, was pleased to announce the launch of its Serum & Plasma Luminex Cytokine Assay, a powerful tool for researchers studying inflammation.
Shirley, New York, United States - April 26, 2023 —
Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company was pleased to announce the launch of its Serum & Plasma Luminex Cytokine Assay, a powerful tool for researchers studying inflammation.
This cutting-edge service enables simultaneous measurement of up to 80 cytokines in a single sample, utilizing the Luminex xMAP technology, providing researchers with an unparalleled level of understanding of the immune response in serum and plasma samples.
Cytokines are small proteins that play a crucial role in the body's immune response. They are involved in the regulation of immune cell activation, differentiation, and proliferation, as well as in the coordination of inflammatory responses. The Serum & Plasma Luminex Cytokine Assay is designed to measure the levels of multiple cytokines simultaneously, providing researchers with a comprehensive picture of the immune response in a given sample.
Inflammatory responses play a critical role in numerous diseases, including autoimmune, cardiovascular, and neurodegenerative disorders, and can be difficult to understand without a detailed analysis of cytokines. With the Serum & Plasma Luminex Cytokine Assay, researchers can detect and quantify cytokines at low levels (down to 0.1 pg/mL), providing valuable insights into the mechanisms of inflammation and the development of targeted treatments.
“The Serum & Plasma Luminex Cytokine Assay is a game-changer for researchers studying inflammation, providing a deeper understanding of the immune response and potential for the development of new treatments for inflammatory diseases,” said the Marketing Director of Creative Proteomics. “Our customizable options for the assay allow researchers to focus on specific cytokines of interest, while our team of scientists ensures that the assay is performed to the highest standard.”
“Creative Proteomics has a professional cytokine detection platform—the Luminex cytokine detection platform. We also offer different analytic strategies, such as real-time quantitative polymerase chain reaction, ELISA and flow cytometry, to meet your unique research needs. We’ll design the most appropriate technology combination according to your project and help researchers obtain higher-quality scientific research data,” he further added.
For researchers interested in the Serum & Plasma Luminex Cytokine Assay, Creative Proteomics offers free consultation services to discuss experimental design and provide guidance on cytokine selection. They also provide comprehensive data analysis services to assist researchers in extracting meaningful information from the data.
About Creative Proteomics
Creative Proteomics is an innovative contract research organization that focuses on using advanced equipment platforms and optimized detection technologies to help researchers around the world reduce time and costs. The company has a proprietary laboratory information management system to strengthen laboratory quality monitoring and management, ensuring the efficiency and security of customer data.
Contact Info:
Name: Dora West
Email: Send Email
Organization: Creative Proteomics
Website: https://www.creative-proteomics.com/
Release ID: 89095829
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
